FDA NDC Directory · JSON-LD · Markdown

Ondansetron

NDC 62135-878 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerChartwell RX, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA077406
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsONDANSETRON (16 mg/1)
Marketing started20061226
Package count1

External sources

Source: openFDA. Public-domain (CC0).